Article Information
PubMed
Published By
Print ISSN
Online ISSN
History
- Received for publication May 21, 2010
- Accepted for publication July 15, 2010
- Published online November 4, 2010.
Copyright & Usage
© 2010 by Society of Nuclear Medicine
Author Information
- Rafke Schoffelen1,
- Winette T.A. van der Graaf2,
- Gerben Franssen1,
- Robert M. Sharkey3,
- David M. Goldenberg3,
- William J. McBride4,
- Edmund A. Rossi5,
- Annemarie Eek1,
- Wim J.G. Oyen1 and
- Otto C. Boerman1
- 1Department of Nuclear Medicine, Radboud University Nijmegen Medical Centre, Nijmegen, The Netherlands
- 2Department of Medical Oncology, Radboud University Nijmegen Medical Centre, Nijmegen, The Netherlands
- 3Garden State Cancer Center, Center for Molecular Medicine and Immunology, Belleville, New Jersey
- 4Immunomedics, Inc., Morris Plains, New Jersey; and
- 5IBC Pharmaceuticals, Inc., Morris Plains, New Jersey
- For correspondence or reprints contact: Rafke Schoffelen, Department of Nuclear Medicine, Radboud University Nijmegen Medical Centre, P.O. Box 9101, 6500 HB Nijmegen, The Netherlands. E-mail: r.schoffelen{at}nucmed.umcn.nl
Statistics from Altmetric.com
Cited By...
Article usage
Jump to section
Related Articles
Cited By...
- {alpha}- Versus {beta}-Emitting Radionuclides for Pretargeted Radioimmunotherapy of Carcinoembryonic Antigen-Expressing Human Colon Cancer Xenografts
- Quantitative Immuno-SPECT Monitoring of Pretargeted Radioimmunotherapy with a Bispecific Antibody in an Intraperitoneal Nude Mouse Model of Human Colon Cancer
- Phase II Trial of Anticarcinoembryonic Antigen Pretargeted Radioimmunotherapy in Progressive Metastatic Medullary Thyroid Carcinoma: Biomarker Response and Survival Improvement